Grading Reproducibility and Reporting in ACC
Diagnostic Scoring and Grading Systems
Grading reproducibility and reporting in adrenocortical carcinoma (ACC) concerns how consistently histopathologic criteria for malignancy are applied and how completely those criteria are documented in pathology reports. Within ACC care, this topic sits within diagnostic scoring and grading systems used to distinguish malignant adrenocortical tumors from adenomas after tissue sampling or resection, and to communicate features that may influence prognosis, staging discussions, and multidisciplinary management.1
This issue is important because ACC is rare, expert pathology review is not uniformly available, and diagnosis still depends largely on morphology rather than on a single definitive ancillary test. Histologic scoring systems are intended to standardize classification, but many of their component findings remain partly observer dependent, especially when they rely on architectural interpretation, invasion assessment, or threshold-based counting. The available evidence is limited and comes largely from retrospective review in specialized centers, so reported reproducibility may overestimate performance in routine practice.1
Current evidence suggests that simpler, rule-based approaches may be more reproducible than broader multiparameter schemes, particularly when observers use standardized definitions and receive targeted calibration or training.1 At the same time, reproducibility does not by itself establish superior prognostic performance or improved patient outcomes. In practice, grading and reporting are therefore best understood as quality-related components of ACC pathology that support, rather than replace, integrated clinical diagnosis and management.
Diagnostic Context
Adrenocortical neoplasms span a spectrum from benign adenoma to overt carcinoma, with some lesions showing borderline or equivocal features. Histologic scoring systems were developed to make this distinction more explicit by anchoring diagnosis to defined microscopic findings such as necrosis, mitotic activity, venous invasion, and disruption of normal adrenal architecture.1
In clinical use, these systems contribute to a broader diagnostic workflow that also includes imaging, endocrine evaluation, operative findings, and clinical course. What appears reliable is that morphology remains central to postresection classification; what is less reliable is the assumption that any single score can resolve every difficult or limited specimen in isolation. The practical implication is that pathology-based grading should be interpreted together with clinical and radiologic context, particularly for uncommon presentations or technically suboptimal samples.
Reproducibility of Histologic Classification
A major concern in ACC pathology is that agreement depends not only on the overall scoring system but also on how clearly its individual criteria are defined. Composite systems may accumulate disagreement when multiple subjective features must be assessed and weighted, whereas simplified algorithms attempt to reduce variability by focusing on a smaller number of findings that can be recognized more consistently.1
The best-supported pattern in the available literature is that a reticulin-based algorithm may provide relatively strong interobserver agreement. In this framework, malignancy is defined by disruption of the reticulin network together with at least one additional adverse feature, such as necrosis, elevated mitotic activity, or venous invasion; retrospective multicenter data suggest substantial reproducibility, with further improvement after observer training.1
This supports the broader principle that standard definitions and calibration may improve consistency across readers. However, it remains uncertain how well this degree of agreement generalizes beyond expert review settings or whether all diagnostically relevant tumor phenotypes fit equally well within simplified schemes. Clinically, the implication is to favor explicit criteria, subspecialty review when available, and local training rather than relying on unstructured impressions alone.
Reporting Quality and Standardization
Reproducibility and reporting quality are closely linked. Even when pathologists reach similar diagnostic conclusions, the clinical usefulness of a report may be limited if the adverse morphologic features underlying that conclusion are not stated clearly. In ACC, this matters because treatment planning, referral review, and research classification often depend on the documented presence or absence of specific findings rather than on the diagnosis label alone.1
Structured or standardized reporting may therefore improve communication by ensuring that core histologic elements are addressed consistently, including the criteria actually used to support malignancy. This appears reliable as a principle of pathology quality and data comparability; what is not yet well established is whether any specific reporting template improves patient-centered outcomes in ACC.1 The practical implication is that reports should identify the scoring approach used and explicitly document key adverse features, especially in cases sent for expert consultation or inclusion in multicenter datasets.
Sources of Variability and Pitfalls
Several factors may reduce grading reproducibility in ACC. Features that seem objective may still require judgment, including assessment of venous invasion, recognition of necrosis, and decisions about whether architectural changes meet diagnostic thresholds. Sampling limitations, tissue preservation, and differences between biopsy material and complete resection specimens may further affect confidence in applying morphology-based criteria.1
These constraints mean that validation studies should not be interpreted as showing uniform performance across all laboratories. What appears reasonably reliable is that simpler criteria may reduce disagreement; what is not reliable is the expectation of consistent interpretation without adequate sampling, training, or specialist experience.1 In practice, equivocal or borderline cases may warrant central pathology review, and reports should acknowledge when specimen limitations prevent confident assessment of specific criteria.
Role in Management and Research
These grading and reporting frameworks have a supportive rather than autonomous role in ACC management. Surgery remains the principal curative-intent treatment for localized disease, and pathology mainly contributes confirmation of malignancy and documentation of adverse features after resection. Reproducible grading may help frame prognosis and follow-up discussions, but it does not replace surgical staging, endocrine assessment, or imaging-based evaluation.
The value of standardization may be especially important in research because the rarity of ACC makes multicenter datasets vulnerable to diagnostic misclassification. More reproducible criteria and more consistent reporting may improve cohort definition and strengthen clinicopathologic analyses, although the evidence remains largely retrospective and methodologic rather than outcome based.1 Overall, current data support harmonized morphology-based assessment, particularly with training and explicit reporting, while broader validation in routine practice remains needed.1
Included Articles
- PMID 23774167: This multicenter validation study supports the reticulin algorithm as a simplified 2-step diagnostic system for adrenocortical tumors, defining malignancy by reticulin framework disruption plus at least one of necrosis, high mitotic rate, or venous invasion. It showed substantial interobserver reproducibility that improved further after training.1